Last reviewed · How we verify
Cryotherapy with liquid nitrogen — Competitive Intelligence Brief
phase 3
Physical ablation therapy
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Cryotherapy with liquid nitrogen (Cryotherapy with liquid nitrogen) — Barretos Cancer Hospital. Cryotherapy with liquid nitrogen destroys tissue by rapid freezing, causing ice crystal formation and cellular death.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cryotherapy with liquid nitrogen TARGET | Cryotherapy with liquid nitrogen | Barretos Cancer Hospital | phase 3 | Physical ablation therapy |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Physical ablation therapy class)
- Barretos Cancer Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cryotherapy with liquid nitrogen CI watch — RSS
- Cryotherapy with liquid nitrogen CI watch — Atom
- Cryotherapy with liquid nitrogen CI watch — JSON
- Cryotherapy with liquid nitrogen alone — RSS
- Whole Physical ablation therapy class — RSS
Cite this brief
Drug Landscape (2026). Cryotherapy with liquid nitrogen — Competitive Intelligence Brief. https://druglandscape.com/ci/cryotherapy-with-liquid-nitrogen. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing